Studies suggest semaglutide may reduce CRP and other inflammatory markers, though these effects may be largely attributable to significant weight reduction rather than direct anti-inflammatory action
Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, et al
In the UK, weight management is approached through a structured, evidence-based framework aligned with NICE guideline CG189 (Obesity: identification, assessment and management) and NICE guideline PH53 (Weight management: lifestyle services for overweight or obese adults)
The placebo effect is a well-described phenomenon, but it never ceases to amaze me
2013, 304, E677E685
Clinical trials show that it lowers HbA1c levels (a measure of long-term blood sugar) and supports weight loss, all while being well-tolerated by patients.[7]